申请人:Kasibhatla Rao Srinivas
公开号:US20070111997A1
公开(公告)日:2007-05-17
Triazolopyrimidines and related compounds are described and demonstrated or predicted to have utility as Heat Shock Protein 90 (HSP90) inhibiting agents in the treatment and prevention of various HSP90 mediated disorders, e.g., proliferative disorders. Method of synthesis and use of such compounds are also described and claimed.
本文描述了三唑并嘧啶类和相关化合物,并证明或预测其在治疗和预防各种HSP90介导的疾病(例如增殖性疾病)中作为热休克蛋白90(HSP90)抑制剂的效用。还描述和声明了这些化合物的合成方法和使用方法。